companydata.dkcompanydata.dk

KATO MEDICAL ApS: Financial statements 2024

CVR: 30703391

Source: annual report 2024, Danish Business Authority

01/01/2024 – 31/12/2024

KATO MEDICAL ApS (CVR 30703391) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -16,158 and a net result of DKK -202,605 compared with DKK 468,896 the year before. Equity in the 2024 report amounted to DKK 1,438,074. The solvency ratio was 95.9%.

Gross Profit
DKK -16,158
Profit/Loss
DKK -202,605
Equity
DKK 1,438,074
Total Assets
DKK 1,498,844

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024--16K-203K1.4M-
2023--15K469K1.9M-
2022--30K73K1.8M-
2021--15K177K2M-
2020--17K419K2.1M-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2024

KATO MEDICAL ApS: The 2023 annual report is outApr 3, 2024

KATO MEDICAL ApS has published its annual report for 2023. Gross profit came to DKK -15,303, and the net result was DKK 468,896.

About KATO MEDICAL ApS

KATO MEDICAL ApS is a Danish company of the type Anpartsselskab based in Værløse, founded in 2007. The company is registered under the industry Speciallægers aktiviteter. The management consists of Karsten Thomsen and Tove Birkebæk Thomsen. The company's owners include Karsten Thomsen, Tove Birkebæk Thomsen and Frederik Ferløv Thomsen. The company has 0 employees (2012). In 2025, the company reported a gross profit of DKK -35,921 and a net result of DKK -687,381 compared with DKK -202,605 the year before. Equity in the 2025 report amounted to DKK 750,693.

Source: annual report 2025, Danish Business Authority